Navigation Links
Lotus Pharmaceuticals, Inc. Reports Second Quarter 2009 Financial Results
Date:8/14/2009

BEIJING, Aug. 14 /PRNewswire-Asia-FirstCall/ -- Lotus Pharmaceuticals, Inc. (OTC Bulletin Board: LTUS) ("Lotus" or the "Company"), a growing developer and producer of prescription drugs and licensed national seller of pharmaceutical products in the People's Republic China, today reported its financial results for the quarter and six months ended June 30, 2009.

    Second Quarter ("Q2") 2009 Highlights and Developments:

    -- Q2 diluted EPS of $0.10
    -- Q2 net income increased 120% to $4.8 million
    -- Q2 gross margin of 57.9% compared to 50.0% in Q2 of 2008
    -- Participated in the April 2009 61st PHARMCHINA in Zhengzhou, China, one
       of the largest exhibitions in Chinese pharmaceutical industry with a
       history of over 30 years, and entered sales agreements with five new
       distributors which the Company believes may increase the Company's
       market share
    -- Exhibited at the June 26-28 2009 International Conference for
       Bioeconomy/the 44th New Drugs Expo and increased its wholesale
       portfolio with three new drugs
    -- Started and completed building foundation of Inner Mongolia new
       facility, which the Company believes accounts for approximately 5% of
       the total build-out
    -- Awarded with Good Supply Practices Certification
    -- Two investors of preferred shares from the 2008 private placement
       financing opted to convert 172,413 shares of preferred stock to 172,413
       shares of common stock of the Company under Rule 144

Revenues for the second quarter of 2009 decreased 30% to $13.6 million from $19.4 million of the same period of 2008. Wholesale revenues, one of the revenue segments, accounting for 78% of total revenues, decreased 25% due to the Company's 2009 product pricing policy(1). Average unit wholesale selling price decreased 43% in the second quarter of 2009 over the same period of 2008, while 26% increase in wholes
'/>"/>

SOURCE Lotus Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related biology technology :

1. Lotus Pharmaceuticals, Inc. Announces Patent Pending Gliclazide-Controlled Release Tablets
2. Lotus Scarless Hair Transplantation (International) Medical Chain Institute Opens New Center on Beijings Prestigious ChangAn Avenue
3. Lotus Pharmaceuticals Announces Second Quarter 2008 Results
4. NovaBay Pharmaceuticals, Inc. Reports Second Quarter 2009 Financial Results
5. Biostar Pharmaceuticals, Inc. Announces Second Quarter 2009 Financial Results
6. Biostar Pharmaceuticals, Inc. to Host Fiscal Year 2009 Second Quarter Earnings Conference Call on Friday, August 14, 2009 at 10:30 a.m. EDT
7. Angiotech Pharmaceuticals, Inc. announces financial results for the second quarter ended June 30, 2009
8. Keryx Biopharmaceuticals, Inc. Announces Second Quarter 2009 Financial Results
9. Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Second Quarter 2009 Financial Results on Thursday, August 6, 2009 at 8:30am EDT
10. Purdue Pharmaceutical Products L.P. and Transcept Pharmaceuticals, Inc. Sign Exclusive Agreement to Commercialize Intermezzo(R) in the United States
11. Angiotech Pharmaceuticals, Inc. announces filing of shelf-registration statement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... 2014 OMICS Group’s 5th International conference ... August, 2014 at Double Tree by Hilton Beijing, China ... in Analytical & Bioanalytical research methods only to facilitate ... this occasion, Dr. Srinubabu Gedela, MD of OMICS Group ... a remarkable one in bringing a unique and international ...
(Date:7/10/2014)...  Kainos Capital, a firm specializing in acquiring and ... has acquired the Slim-Fast brand from Unilever. Unilever will ... the transaction were not disclosed. Slim-Fast is ... markets ready-to-drink shakes, powders, bars and snacks to retail ... in the United Kingdom and ...
(Date:7/10/2014)... may help in the fight against terrorism with the ... of explosives with the use of light and special ... and Actuators B: Chemical , the researchers describe a ... concentrations as low as 6.3 ppm (parts per million). ... minutes. , "Traditionally explosives detection has involved looking for ...
(Date:7/10/2014)... our laptops and electric vehicles could store more energy ... help of a sponge-like silicon material. , Researchers ... used in one of the battery,s electrodes, as silicon ... of graphite. A paper describing the material,s performance as ... Nature Communications . , "Silicon has long been sought ...
Breaking Biology Technology:A Critical Review of Analytical Techniques for Improved Living Standards 2A Critical Review of Analytical Techniques for Improved Living Standards 3A Critical Review of Analytical Techniques for Improved Living Standards 4Kainos Capital Acquires Slim-Fast From Unilever 2Detecting trace amounts of explosives with light 2Silicon sponge improves lithium-ion battery performance 2Silicon sponge improves lithium-ion battery performance 3
... Grow to $10.5 Million in 2007; MOXATAG, Company,s Lead, PULSYS ... ... Alternatives Ongoing, GERMANTOWN, Md., March 4 ... focused on,developing and commercializing novel anti-infective products, today,announced financial and ...
... LAS VEGAS, March 4 ,Cord Blood America, Inc. ... cell preservation company ( http://www.cordblood-america.com ),focused on ... to families,nationwide and internationally, today announced its wholly ... on car #49 at the Sunday, March 2, ...
... For centuries, engineers have bent and torn metals to ... the University of Pennsylvania School of Engineering and Applied ... sizes in the form of wires a thousand times ... Penn engineers to construct a theoretical model to predict ...
Cached Biology Technology:MiddleBrook Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results 2MiddleBrook Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results 3MiddleBrook Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results 4MiddleBrook Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results 5MiddleBrook Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results 6MiddleBrook Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results 7MiddleBrook Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results 8MiddleBrook Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results 9MiddleBrook Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results 10MiddleBrook Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results 11MiddleBrook Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results 12MiddleBrook Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results 13MiddleBrook Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results 14MiddleBrook Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results 15Cord Blood America Subsidiary Featured at NASCAR Sprint Cup Series Race 2Cord Blood America Subsidiary Featured at NASCAR Sprint Cup Series Race 3Surface dislocation nucleation: Strength is but skin deep at the nanoscale, Penn engineers discover 2
(Date:7/11/2014)... WASH. July 11, 2014 Researchers have ... three-dimensional images. The new technology, called Virtual Finger, ... small structures like neurons and synapses using the ... unique technology makes 3D imaging studies orders of ... at an unprecedented level across many areas of ...
(Date:7/11/2014)... that transplantation of mesenchymal stem cells can stimulate neurogenesis ... of Alzheimer,s disease (AD) and improve tissue and function ... are reported on the therapeutic effect of adipose-derived stem ... the effect on oxidative injury and neurogenesis in the ... team, School of Life Sciences, Tsinghua University, China transplanted ...
(Date:7/11/2014)... under the normal circumstances, astrocytes participate in ... environment, and exhibit therapeutic and repairing effects ... studies have found that nerve cells differentiated ... have reduced viability, which produces influences on ... Kailuan General Hospital, Hebei United University, China ...
Breaking Biology News(10 mins):Virtual finger enables scientists to navigate and analyze complex 3D images 2
... suffer severe burns. The resulting large, deep wounds caused by ... is needed to reduce this kind of scarring is the ... of skin can be removed from the individual patient as ... grafting, another option is to engineer a skin graft in ...
... centres in synthetic biology will be established in ... to funding from the Biotechnology and Biological Sciences ... Sciences Research Council (EPSRC). The 40M+ investment ... and Science David Willetts tonight at a BBSRC ...
... have had bariatric surgery may need to take dietary ... a UT Southwestern Medical Center study suggests. The ... , tracked a group of gastric banding patients and ... most still did not meet recommended daily requirements for ...
Cached Biology News:Blood and lymphatic capillaries grown for the first time in the lab 2UK establishes 3 new synthetic biology research centers 2Gastric banding patients should closely monitor nutrition following surgery 2Gastric banding patients should closely monitor nutrition following surgery 3